MetEnk has also been reported to effectively prevent body weight gain in mice treated with HFD through promoting browning of adipose tissue and can enhance glucose tolerance and insulin sensitivity, and was considered a potential therapy for metabolic disorders [76], but the underlying mechanisms are unclear. The gene discussed is INS; the disease is Other metabolic disease.